Position in ANNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,700,438
+$1,083,691 QoQ
Shares Held
297,800
+142.4% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#68
of 216 holders
Holding Since
Dec 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jump Financial, LLC holds $441,487,523 across 168 Biotechnology names. ANNX ranks #69 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
306,330 | $24,288,904 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
579,882 | $22,621,196 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
260,730 | $15,737,662 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
277,952 | $15,159,500 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
245,390 | $14,041,214 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
679,445 | $12,209,626 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,242 | $10,127,536 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
286,952 | $9,581,327 |
All Filings in ANNX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,700,438 | 297,800 | Shares | Defined | 2026-08-13 | |
| 2025-12-31 | $616,747 | 122,858 | Shares | Defined | 2026-02-17 | |
| 2024-06-30 | $210,469 | 42,953 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $1,507,134 | 210,200 | Shares | Sole | 2024-05-13 | |
| 2023-03-31 | $120,759 | 31,366 | Shares | Sole | 2024-10-21 | |
| 2022-12-31 | $62,659 | 12,120 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $100,737 | 36,900 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $464,161 | 40,397 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||